We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
TIGS and ICAR – IIRR sign MoU
📝 TIGS and ICAR - IIRR ink MoU! Climate change presents a significant... read more
Talk by Dr. Rakesh Mishra at Rare Diseases Summit 2023
Dr Rakesh Mishra, Director, Tata Institute for Genetics and Society, was invited... read more
On the new recent surge in Covid 19 cases and JN.1 variant
The Tata Institute for Genetics and Society (TIGS) has been conducting sewage... read more
Award to Dr. Mansi Malik
Dr. Mansi Malik, Scientist at TIGS recently won the 'Best Turbo Talk... read more
REDRESS 2025: A Two-Day Convergence on Rare Genetic Diseases
Click here for REDRESS 2025 meeting proceedings The 4th Rare Genetic Diseases Research... read more
Pandemic Far From Over, Amp Up Surveillance, Says Scientist Tracking Covid In India’s Wastewaters
Environmental surveillance of Covid-19 will be critical over the next two years.... read more
Talk by Dr. Sresty Tavva at ‘Sugar rush with science’ event by C-CAMP
Dr. V S Sresty Tavva, Principal Scientist at TIGS recently delivered a... read more
WHONET 2 day workshop – Dr. Mansi Malik
Antimicrobial resistance (AMR) has been identified as a serious global and national... read more
An Uphill Battle
Dr. Vasanth Thamodaran, Senior Scientist at TIGS was featured in an article... read more
Press Release: Researchers Unveil Detailed Genome of Malaria Mosquito Vector
New ‘gold standard’ reference genome reveals thousands of new genes vital for... read more

